Vitamin E-coated cellulose acetate dialysis membrane: long-term effect on inflammation and oxidative stress

REFERENCES

• Kaysen GA. The microinflammatory state in uremia: Causes and potential consequences. J Am Soc Nephrol. 2001;12:1549–1557.
   PubMed Web of Science ®Google Scholar
• Rayner HC, Pisoni RL, Bommer J, Mortality and hospitalization in hemodialysis patients in five European countries: Results from the dialysis outcomes and practice patterns study (DOPPS). Nephrol Dial Transplant. 2004;19:108–120.
   PubMed Web of Science ®Google Scholar
• Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–1305.
   PubMed Web of Science ®Google Scholar
• Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C. Oxidative stress in end-stage renal disease: An emerging threat to patient outcome. Nephrol Dial Transplant. 2003;18:1272–1280.
   PubMed Web of Science ®Google Scholar
• Spittle MA, Hoenich NA, Handelman GJ, Adhikarla R, Homel P, Levin NW. Oxidative stress and inflammation in hemodialysis patients. Am J Kidney Dis. 2001;38:1408.
   PubMed Web of Science ®Google Scholar
• Satoh M, Yamasaki Y, Nagake Y, Oxidative stress is reduced by the long-term use of vitamin E-coated dialysis filters. Kidney Int. 2001;59:1943–1950.
   PubMedGoogle Scholar
• Morimoto H, Nakao K, Fukuoka K, Long-term use of vitamin E-coated polysulphone membrane reduces oxidative stress markers in hemodialysis patients. Nephrol Dial Transplant. 2005;20:2775–2782.
   PubMedGoogle Scholar
• Betjes MG, Hoekstra FM, Klepper M, Postma SM, Vaessen LM. Vitamin E-coated dialyzer membranes downregulate expression of monocytes adhesion and co-stimulatory molecules. Blood Purif. 2004;22(6):510–517.
   Google Scholar
• Morena M, Gausson V, Mothu N, Regional variations of low-density lipoprotein oxidizability in hemodialysis patients may explain discrepancies in interventional therapy on oxidative profile. Blood Purif. 2008;26:300–310.
   PubMed Web of Science ®Google Scholar
• Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: The FRAP assay. Anal Biochem. 1996;239:70–76.
   PubMed Web of Science ®Google Scholar
• Cesarone MR, Belgaro G, Carratelli M, A simple test to monitor oxidative stress. Int Angiol. 1999;18:127–130.
   PubMed Web of Science ®Google Scholar
• Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM. The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 2002;62:1524–1538.
   PubMed Web of Science ®Google Scholar
• Jaber BL, Pereira BJ. Biocompatibility of hemodialysis membranes. In: Pereira B, Sayegh M, Blake P, eds. Chronic Kidney Disease, Dialysis and Transplantation: A Companion to Brenner and Rector's The Kidney. 2nd ed. Philadelphia, PA: Elsevier Saunders; 2005:363–387.
   Google Scholar
• Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973–979.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836–843.
   PubMed Web of Science ®Google Scholar
• Owen WF, Lowrie EG. C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int. 1998;54:627–663.
   PubMed Web of Science ®Google Scholar
• Weinhold B, Bader A, Poli V, Ruther U. Interleukin-6 is necessary, but not sufficient, for induction of the human C-reactive protein gene in vivo. Biochem J. 1997;325:617–621.
   PubMed Web of Science ®Google Scholar
• Lowrie EG. Acute-phase inflammatory process contributes to malnutrition, anemia, and possibly other abnormalities in dialysis patients. Am J Kidney Dis. 1998;32:S105–S112.
   Google Scholar
• Bistrian BR. Role of the systemic inflammatory response syndrome in the development of protein-calorie malnutrition in ESRD. Am J Kidney Dis. 1998;32:S113–S117.
   Google Scholar
• Kopple JD. Pathophysiology of protein-energy wasting in chronic renal failure. J Nutr. 1999;129:247S–251S.
   Google Scholar
• Nguyen-Khoa T, Massy ZA, De Bandt JP, Oxidative stress and hemodialysis: Role of inflammation and duration of dialysis treatment. Nephrol Dial Transplant. 2001;16:335–340.
   PubMed Web of Science ®Google Scholar
• Handelman GJ, Walter MF, Adhikarla R, Elevated plasma F2-isoprostanes in patients on long-term hemodialysis. Kidney Int. 2001;59:1960–1966.
   PubMed Web of Science ®Google Scholar
• Himmelfarb J, Kane J, McMonagle E, Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal disease. Kidney Int. 2003;64:978–991.
   PubMed Web of Science ®Google Scholar
• Iseki K, Tozawa M, Yoshi S, Fuyikama K. Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients. Nephrol Dial Transplant. 1999;14:1956–1960.
   PubMed Web of Science ®Google Scholar
• Yeun JY, Levine RA, Mantadilok V, Kaysen GA. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis. 2000;35:469–476.
   PubMed Web of Science ®Google Scholar
• Hensley K, Robinson KA, Gabbita SP, Salsman S, Floyd RA. Reactive oxygen species, cell signaling, and cell injury. Free Radic Biol Med. 2000;28:1456–1462.
   PubMed Web of Science ®Google Scholar
• Rosen GM, Pou S, Ramos CL, Cohen MS, Britigan BE. Free radicals and phagocytic cells. FASEB J. 1995;9:200–209.
   PubMed Web of Science ®Google Scholar
• Girndt M, Lengler S, Kaul H, Sester U, Sester M, Köhler H. Prospective crossover trial of the influence of vitamin E-coated dialyzer membranes on T-cell activation and cytokine induction. Am J Kidney Dis. 2000;35(1):95–104.
   Google Scholar
• Azzi A, Boscoboinik D, Hensey C. The protein kinase C family. Eur J Biochem. 1992;208(3):547–557.
   Google Scholar
• Mydlík M, Derzsiová K, Rácz O, Vitamin E-coated dialyzer and antioxidant defense parameters: Three-month study. Semin Nephrol. 2004;24(5):525–531.
   PubMed Web of Science ®Google Scholar
• Durak I, Akyol O, Başeşme E, Canbolat O, Kavutçu M. Reduced erythrocyte defense mechanisms against free radical toxicity in patients with chronic renal failure. Nephron. 1994;66(1):76–80.
   Google Scholar
• Ceballos-Picot I, Witko-Sarsat V, Merad-Boudia M, Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure. Free Radic Biol Med. 1996;21(6):845–853.
   PubMed Web of Science ®Google Scholar
• Boran M, Küçükaksu C, Balk M, Cetin S. Red cell lipid peroxidation and antioxidant system in hemodialysed patients: Influence of recombinant human erythropoietin (r-HuEPO) treatment. Int Urol Nephrol. 1998;30(4):507–512.
   PubMedGoogle Scholar
• Zimmermann J, Herrlinger S, Pruy A, Metzeger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999;55:648–658.
   PubMed Web of Science ®Google Scholar
• Honda H, Qureshi AR, Heimbürger O, Serum albumin, C-reactive protein, interleukin 6 and Fetuin A as predictors of malnutrition, cardiovascular disease and mortality in ESRD patients. Am J Kidney Dis. 2006;47:139–148.
   PubMed Web of Science ®Google Scholar
• Senol E, Ersoy A, Erdinc S, Sarandol E, Yurtkuran M. Oxidative stress and ferritin levels in hemodialysis patients. Nephrol Dial Transplant. 2008;23:665–672.
   Google Scholar
• Menon V, Greene T, Wang X, C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int. 2005;68:766–772.
   PubMed Web of Science ®Google Scholar
• Paul JL, Sall ND, Soni T, Lipid peroxidation abnormalities in hemodialyzed patients. Nephron. 1993;64(1):106–109.
   Google Scholar
• Mydlík M, Derzsiová K, Rácz O, A modified dialyzer with vitamin E and antioxidant defense parameter. Kidney Int Suppl. 2001;78:S144–S147.
   Google Scholar